Skip to main content
Equibles

CITIGROUP INC

Position in NEO — Neogenomics Inc

CIK 831001 NEW YORK, NY
Back to NEO Full portfolio

Position in NEO

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$9,748,716
+$5,171,824 QoQ
Shares Held
668,178
+8.3% QoQ
Ownership
0.520%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $1,347,844,187 across 35 Diagnostics & Research names. NEO ranks #18 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 650,976 $326,373,326
2 DHR
Danaher Corp /De/
 778,298 $148,250,202
3 MTD
Mettler Toledo International Inc/
 90,754 $115,939,141
4 IDXX
Idexx Laboratories Inc /De
 165,689 $87,225,316
5 ILMN
Illumina, Inc.
 465,311 $81,815,632
6 WAT
Waters Corp /De/
 213,227 $79,968,652
7 CRL
Charles River Laboratories International, Inc.
 316,217 $71,714,852
8 DGX
Quest Diagnostics Inc
 315,584 $66,888,027

All Filings in NEO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,748,716 668,178
2026-03-31 $4,576,892 616,832
2025-12-31 $366,005 31,123
2025-09-30 $1,380,844 178,866
2025-06-30 $828,009 113,271
2025-03-31 $1,745,702 183,952
2024-12-31 $3,046,409 184,855
2024-09-30 $2,438,292 165,308
2024-06-30 $1,347,690 97,166
2024-03-31 $1,417,470 90,170
2023-12-31 $1,322,374 81,729
2023-09-30 $678,085 55,129
2023-06-30 $1,593,178 99,140
2023-03-31 $1,134,173 65,145
2022-12-31 $784,215 84,872
2022-09-30 $562,798 65,366
2022-06-30 $2,945,458 361,406
2022-03-31 $4,498,208 370,223
2021-12-31 $3,658,208 107,216
2021-09-30 $4,761,431 98,703
2021-06-30 $4,868,195 107,775
2021-03-31 $1,573,984 32,635
2020-12-31 $5,757,863 106,944
2020-09-30 $1,707,451 46,285
2020-06-30 $8,265,958 266,816
2020-03-31 $1,611,732 58,375